Grifols (Grifols) Market Cap

: $5,677 Mil (As of Today)

View and export this data going back to 2008. Start your Free Trial

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Grifols's share price for the quarter that ended in Sep. 2023 was $6.35. Grifols's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 1,358 Mil. Therefore, Grifols's market cap for the quarter that ended in Sep. 2023 was $8,624 Mil.

Grifols's quarterly market cap increased from Dec. 2022 ($7,795 Mil) to Jun. 2023 ($8,670 Mil) but then declined from Jun. 2023 ($8,670 Mil) to Sep. 2023 ($8,624 Mil).

Grifols's annual market cap declined from Dec. 2021 ($12,607 Mil) to Dec. 2022 ($7,795 Mil) but then increased from Dec. 2022 ($7,795 Mil) to Dec. 2023 ($11,816 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Grifols's Enterprise Value for Today is $19,425 Mil.

Grifols Market Cap Historical Data

The historical data trend for Grifols's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

24,560.63

21,152.44

12,607.27

7,794.93

11,816.17

Grifols Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Market Cap																6,146.39	7,794.93	8,670.08	8,624.44	11,816.17

Competitive Comparison

For the Drug Manufacturers - General subindustry, Grifols's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols Market Cap Distribution

For the Drug Manufacturers industry and Healthcare sector, Grifols's Market Cap distribution charts can be found below:

* The bar in red indicates where Grifols's Market Cap falls into.

Grifols Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Grifols's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$8.7	*	1358.18
	=	$11,816

Grifols's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )	=	Share Price (Q: Sep. 2023 )	*	Shares Outstanding (EOP) (Q: Sep. 2023 )
	=	$6.35	*	1358.18
	=	$8,624

Grifols (OTCPK:GIKLY) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Grifols Market Cap Related Terms

Thank you for viewing the detailed overview of Grifols's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols (Grifols) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (OTCPK:GIKLY) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

GIFOF:USA GIFLF:USA GRFS:USA GRFP:Mexico GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain OZTA:Germany

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.